# Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury

> **NCT03945110** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Western Australia** · enrollment: 10 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **DEVICE:** iAluRil® intravesical instillations

## Key facts

- **NCT ID:** NCT03945110
- **Lead sponsor:** The University of Western Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-18
- **Primary completion:** 2020-09-22
- **Final completion:** 2021-03-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945110, "Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03945110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*